The authors discuss the evolution of the purification platform for manufacturing of mAb therapeutics.
Nihal Tugcu
Advertisement
Nihal Tugcu is senior principal scientist at Bioprocess Development, Merck Sharp & Dohme Corp, Kenilworth, New Jersey, USA.
Articles by Nihal Tugcu
Advertisement
Latest Updated Articles
Evolution of the Monoclonal Antibody Purification PlatformNovember 1st 2013
Advertisement
Advertisement